Study title:
Clinical Study of Daunomycin (NSC-82151) in children with acute leukemia - Holton, C.P., Lonsdale, D., Nora, A. H., Thurman, W.G., Vietti, T.J. - 1968 (Cancer Vol. 22 N° 5, 1014 - 1017)
- Publication in the dos. Allemand jan 1981 - Clinical Study of Daunomycin (NSC-82151) in children with acute leukemia - Holton, C.P., Lonsdale, D., Nora, A. H., Thurman, W.G., Vietti, T.J. - 1968 (Cancer Vol. 22 N° 5, 1014 - 1017)
- Publication in the dos. Allemand jan 1981 -
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: DAUNORUBICIN |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|